Colostrum, often called âliquid goldâ, has taken over longevity circles, biohacking podcasts, and premium supplement shelves. Marketed for everything from gut health to immune resilience and anti-aging, its popularity has surged faster than human clinical research.
In Episode 81 of the Orange Pill Podcast, we break down a newly published randomized, double-blind, placebo-controlled clinical trial from the Journal of Functional Foods that finally puts colostrum to the test in adults aged 55â70.
This episode explores what the data actually shows:
⢠Colostrumâs antibodies survive digestion and remain bioactive in the gut
⢠IGF-1 levels increased while age-related decline continued in the placebo group
⢠Participants saw reduced leg fat accumulation, suggesting metabolic preservation
⢠Markers pointed toward immune priming, not just passive immunity
⢠No short-term changes in bone density or cognition - a reality check on timelines
⢠A strong safety profile, with mostly mild, short-term digestive effects
Rather than a miracle cure, this study positions colostrum as a biologically active, patience-requiring intervention for immune and metabolic resilience in aging populations.